Lincoln Capital Corp’s Chemours CC Stock Holding History

Lincoln Capital Corp’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,190	Closed	-$208K	–	69
2021 Q4	$208K	Buy	+6,190	New	+$193K	0.1%	66

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lincoln Capital Corp's CC Position: Q1 2022 in Review

Lincoln Capital Corp sold out of Chemours (CC) in Q1 2022, closing a stake of 6,190 shares — an estimated $208K sold.

Lincoln Capital Corp first reported a position in CC in Q4 2021 and held it in 1 quarter. The position peaked at $208K in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Lincoln Capital Corp reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Lincoln Capital Corp sold 6,190 Chemours shares in Q1 2022, an estimated $208K.
Lincoln Capital Corp first reported a position in Chemours in Q4 2021 and held it in 1 quarter.
Lincoln Capital Corp's Chemours position peaked at $208K in Q4 2021.
481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Lincoln Capital Corp's 13F filing for Q1 2022, filed 19 Apr 2022.